Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that two oral presentations and a poster presentation featuring data for the company’s NeXT ...

What if routine doping tests could do more than uphold the integrity of sports? What if they could save lives? In a game-changing move, FP7McCann Dubai, in collaboration with the Testicular Cancer ...

The campaign aims to raise awareness about male incontinence and related health issues, such as prostate cancer.

Data From GRAIL's ctDNA-based Targeted Methylation Assay Highlight Potential to Identify Robust Signals of Promoter Methylation MENLO PARK, Calif., April 22, 2025 /PRNewswire/ -- ...

Manitoba Health Minister Uzoma Asagwara ordered the province’s health authority, Shared Health, to kill a tongue-in-cheek ...

Breast cancer is the most common cancer in women, with one in eight women being afflicted in their lifetime. It is estimated that more than 30,000 Canadian women were diagnosed with breast cancer in ...

Mainz Biomed and Thermo Fisher Scientific signed a collaboration agreement for the development of the Company’s next generation colorectal cancer ... standards in early cancer detection.

Kairos Pharma, Ltd. is a clinical stage company involved in treating EGFR-driven lung cancer patients with ENV105 in combination with osimertinib after they fail to respond to single-agent osimertinib ...

Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing efimosfermin alfa, an investigational, once-monthly FGF21 analogue for the treatment of metabolic dysfunction-associated ...

A key catalyst for Bunch's pursuit of entrepreneurship was the WKU Innovation Campus, an intellectual hub that bridges ...